Cold Chain

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Delphine Perridy, chief commercial officer, Envirotainer, explains why ultra-precise temperature control and customized logistics solutions are critical when it comes to biologics and personalized medicine.

The partnership focuses on the expansion of real-time monitoring and other intelligence services.

The hub is intended to assist customers with achieving better sustainability by providing the necessary tools to do so.

Building strategy, mitigating risk, and achieving success with artificial intelligence.

Various forms of technology—including in the serialization and refrigeration spaces—are necessary in order to keep goods flowing smoothly through the supply chain.

Alongside the proper temperature-monitoring technology, optimal production control is necessary for success in cold chain drug delivery.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Gautam Prem Jain, GoComet’s Co-founder and CEO, discusses obstacles encountered by shippers in the pharmaceutical sector.

A panel offers its perspective on bolstering the temperature monitoring and data sharing process.

The parties’ want to provide customers with a “one-stop-shop,” with the hopes that their services will be easier to navigate.

The company boosts its healthcare logistics services by agreeing to purchase Frigo-Trans and its sister company BPL.

How can industry stakeholders ensure the quality and supply chain security of existing product?

The 8,000 square-foot facility—located within the wholesaler’s Le Vergne distribution center— is expected to help tackle cell and gene therapy logistical challenges.

The 3PL plans to convert all its trucks to electric by 2027.

The Silverpod MAX RE offers real-time shipment visibility, while also helping companies accomplish their sustainability goals.

The San Antonio facility will be taking this biomanufacturing initiative by the end of Q3 2024.

The investment is expected to help enhance the company temperature-controlled services in the Netherlands, France, Italy, and Hungary.

The deal also adds a spread of supply chain efficiency, sustainability, and patient safety outcomes to the mix.

The company’s European Hub facility in Roermond is expanding by over 235,000 square feet, and will be dedicated to accommodating freezer farm capacity.

The 53,000 square-foot facility is expected to become a Northeastern biotech hub, and will be home to various CGT services.

The company's latest service provides risk and quality management for the pharma and healthcare sectors.

The Netherlands plant is expected to provide solutions that can help further the development of advanced therapies.

The document reiterates the company’s commitment to ESG principles, including carbon neutrality by 2030.

The company has financially committed $13.1 million into the project.

A one-on-one with Thermo Fisher’s Wilfredo Marin, who dives into the value of ultra-low temperature storage, the need for flexibility in the cold chain logistics space, and more.

Session addresses the challenges of implementing autologous/allogeneic cell gene therapies into scalable networks.